We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Vaccine Committee Recommends Moderna Vaccine for Two Pediatric Age Groups
FDA Vaccine Committee Recommends Moderna Vaccine for Two Pediatric Age Groups
The FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously, 22-0, yesterday to recommend FDA authorization of Moderna’s two-dose primary series of its COVID-19 vaccine for children between the ages of 12 and 17 and between six and 11.